Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells

Journal of Hepatology

Volumn 51, Issue 3, 2009, Pages 446-457

  Eyre, Nicholas S ^a,b   Phillips, Renee J ^a,b   Bowden, Scott ^c   Yip, Evelyn ^a,b   Dewar, Ben ^c   Locarnini, Stephen A ^c   Beard, Michael R ^a,b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

Co infection; HBV; HCV; Hepatocytes; Pathogenesis; Superinfection

Indexed keywords

ADENOVIRUS VECTOR; HEPATITIS B SURFACE ANTIGEN; VIRUS PROTEIN;

ARTICLE; CELL STRAIN; CELL STRAIN HUH 7; CHRONIC LIVER DISEASE; CONTROLLED STUDY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MIXED INFECTION; PRIORITY JOURNAL; VIRION; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS REPLICATION;

ADENOVIRIDAE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA, VIRAL; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; HEPACIVIRUS; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; RNA, VIRAL; VIRUS REPLICATION;

EID: 68049137312     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.04.025     Document Type: Article

References (43)

1. Alberti A., Pontisso P., Chemello L., Fattovich G., Benvegnu L., Belussi F., et al. The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease. J Hepatol 22 (1995) 38-41
2. Yang H.I., Lu S.N., Liaw Y.F., You S.L., Sun C.A., Wang L.Y., et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347 (2002) 168-174
3. Sun C.A., Wu D.M., Lin C.C., Lu S.N., You S.L., Wang L.Y., et al. Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan. Am J Epidemiol 157 (2003) 674-682
4. Liaw Y.F., Chen Y.C., Sheen I.S., Chien R.N., Yeh C.T., and Chu C.M. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 126 (2004) 1024-1029
5. Raimondo G., Pollicino T., Cacciola I., and Squadrito G. Occult hepatitis B virus infection. J Hepatol 46 (2007) 160-170
6. Sheen I.S., Liaw Y.F., Chu C.M., and Pao C.C. Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection. J Infect Dis 165 (1992) 831-834
7. Sato S., Fujiyama S., Tanaka M., Yamasaki K., Kuramoto I., Kawano S., et al. Coinfection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 21 (1994) 159-166
8. Chu C.M., Yeh C.T., and Liaw Y.F. Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection. J Clin Microbiol 36 (1998) 2084-2086
9. Tseng F.C., Edlin B.R., Zhang M., Kral A., Busch M.P., Ortiz-Conde B.A., et al. The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use. J Viral Hepat (2008)
10. Zarski J.P., Bohn B., Bastie A., Pawlotsky J.M., Baud M., Bost-Bezeaux F., et al. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 28 (1998) 27-33
11. Chu C.M., Yeh C.T., Sheen I.S., and Liaw Y.F. Acute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCV. Gut 51 (2002) 95-99
12. Biliotti E., Kondili L.A., Furlan C., Ferretti G., Zacharia S., De Angelis M., et al. Acute hepatitis B in patients with or without underlying chronic HCV infection. J Infect (2008)
13. Rodriguez-Inigo E., Bartolome J., Ortiz-Movilla N., Platero C., Lopez-Alcorocho J.M., Pardo M., et al. Hepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection. J Virol 79 (2005) 15578-15581
14. Shih C.M., Lo S.J., Miyamura T., Chen S.Y., and Lee Y.H. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 67 (1993) 5823-5832
15. Schuttler C.G., Fiedler N., Schmidt K., Repp R., Gerlich W.H., and Schaefer S. Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J Hepatol 37 (2002) 855-862
16. Chen S.Y., Kao C.F., Chen C.M., Shih C.M., Hsu M.J., Chao C.H., et al. Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein. J Biol Chem 278 (2003) 591-607
17. Guo H., Zhou T., Jiang D., Cuconati A., Xiao G.H., Block T.M., et al. Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway. J Virol 81 (2007) 10072-10080
18. Rouille Y., Helle F., Delgrange D., Roingeard P., Voisset C., Blanchard E., et al. Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. J Virol 80 (2006) 2832-2841
19. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11 (2005) 791-796
20. Delaney W., and Isom H.C. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus. Hepatology 28 (1998) 1134-1146
21. Honda M., Kaneko S., Matsushita E., Kobayashi K., Abell G.A., and Lemon S.M. Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation. Gastroenterology 118 (2000) 152-162
22. Ikeda M., Yi M., Li K., and Lemon S.M. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J Virol 76 (2002) 2997-3006
23. Helbig K.J., Lau D.T., Semendric L., Harley H.A., and Beard M.R. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 42 (2005) 702-710
24. Hadlock K.G., Lanford R.E., Perkins S., Rowe J., Yang Q., Levy S., et al. Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes. J Virol 74 (2000) 10407-10416
25. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., et al. Complete replication of hepatitis C virus in cell culture. Science 309 (2005) 623-626
26. Ishida S., Kaito M., Kohara M., Tsukiyama-Kohora K., Fujita N., Ikoma J., et al. Hepatitis C virus core particle detected by immunoelectron microscopy and optical rotation technique. Hepatol Res 20 (2001) 335-347
27. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102 (2005) 9294-9299
28. Chin R., Earnest-Silveira L., Koeberlein B., Franz S., Zentgraf H., Dong X., et al. Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: factors contributing to hepatocarcinogenesis. J Hepatol 47 (2007) 325-337
29. Drummer H.E., Maerz A., and Poumbourios P. Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. FEBS Lett 546 (2003) 385-390
30. Ning B., and Shih C. Nucleolar localization of human hepatitis B virus capsid protein. J Virol 78 (2004) 13653-13668
31. Lambert C., Doring T., and Prange R. Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin. J Virol 81 (2007) 9050-9060
32. Appel N., Zayas M., Miller S., Krijnse-Locker J., Schaller T., Friebe P., et al. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog 4 (2008) e1000035
33. Miyanari Y., Atsuzawa K., Usuda N., Watashi K., Hishiki T., Zayas M., et al. The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9 (2007) 1089-1097
34. Tellinghuisen T.L., Foss K.L., and Treadaway J. Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. PLoS Pathog 4 (2008) e1000032
35. Schaller T., Appel N., Koutsoudakis G., Kallis S., Lohmann V., Pietschmann T., et al. Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes. J Virol 81 (2007) 4591-4603
36. Tscherne D.M., Evans M.J., von Hahn T., Jones C.T., Stamataki Z., McKeating J.A., et al. Superinfection exclusion in cells infected with hepatitis C virus. J Virol 81 (2007) 3693-3703
37. Potthoff A., Wedemeyer H., Boecher W.O., Berg T., Zeuzem S., Arnold J., et al. The HEP-NET B/C co-infection trial: a prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection. J Hepatol 49 (2008) 688-694
38. Raimondo G., Brunetto M.R., Pontisso P., Smedile A., Maina A.M., Saitta C., et al. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. Hepatology 43 (2006) 100-107
39. Saitta C., Pontisso P., Brunetto M.R., Fargion S., Gaeta G.B., Niro G.A., et al. Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy. Antivir Ther 11 (2006) 931-934
40. Boulant S., Targett-Adams P., and McLauchlan J. Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus. J Gen Virol 88 (2007) 2204-2213
41. Shavinskaya A., Boulant S., Penin F., McLauchlan J., and Bartenschlager R. The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. J Biol Chem 282 (2007) 37158-37169
42. Watanabe T., Sorensen E.M., Naito A., Schott M., Kim S., and Ahlquist P. Involvement of host cellular multivesicular body functions in hepatitis B virus budding. Proc Natl Acad Sci USA 104 (2007) 10205-10210
43. Anzola M. Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J Viral Hepat 11 (2004) 383-393